{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T11:56:54Z","timestamp":1789646214926,"version":"4.0.0"},"reference-count":52,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2012,11,15]],"date-time":"2012-11-15T00:00:00Z","timestamp":1352937600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1003030","type":"journal-article","created":{"date-parts":[[2012,11,15]],"date-time":"2012-11-15T22:39:14Z","timestamp":1353019154000},"page":"e1003030","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":136,"title":["Sensitivity of Mitochondrial Transcription and Resistance of RNA Polymerase II Dependent Nuclear Transcription to Antiviral Ribonucleosides"],"prefix":"10.1371","volume":"8","author":[{"given":"Jamie J.","family":"Arnold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh D.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy Y.","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian S.","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Smidansky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria L.","family":"Kireeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aesop","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer E.","family":"Vela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeojin","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yili","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darius","family":"Babusis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ona","family":"Barauskus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blake R.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Averell","family":"Gnatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail","family":"Kashlev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig E.","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,11,15]]},"reference":[{"key":"ref1","unstructured":"Braaten D, editor(1975) Chemistry, Biology, and Clinical Use of Nucleoside Analogs. 3\u2013610 p."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/med.2610040403","article-title":"Molecular bases for the action and selectivity of nucleoside antibiotics","volume":"4","author":"L Carrasco","year":"1984","journal-title":"Med Res Rev"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0079-6603(08)60236-6","article-title":"Nucleoside antibiotics","volume":"5","author":"JJ Fox","year":"1966","journal-title":"Prog Nucleic Acid Res Mol Biol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1517\/13543780902854194","article-title":"Progress towards improving antiviral therapy for hepatitis C with hepatitis C virus polymerase inhibitors. Part I: Nucleoside analogues","volume":"18","author":"NA Brown","year":"2009","journal-title":"Expert Opin Investig Drugs"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2174\/138955706776876212","article-title":"Pharmacological and clinical studies on purine nucleoside analogs\u2013new anticancer agents","volume":"6","author":"E Lech-Maranda","year":"2006","journal-title":"Mini Rev Med Chem"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1517\/13543784.2011.554822","article-title":"New nucleoside analogs for patients with hematological malignancies","volume":"20","author":"T Robak","year":"2011","journal-title":"Expert Opin Investig Drugs"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.2174\/092986706778742918","article-title":"Purine nucleoside analogs as immunosuppressive and antineoplastic agents: mechanism of action and clinical activity","volume":"13","author":"T Robak","year":"2006","journal-title":"Curr Med Chem"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev-micro-090110-102954","article-title":"Turning hepatitis C into a real virus","volume":"65","author":"CL Murray","year":"2010","journal-title":"Annu Rev Microbiol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1074\/jbc.M510195200","article-title":"The novel nucleoside analog R1479 (4\u2032-azidocytidine) is a potent inhibitor of NS5B-dependent RNA synthesis and hepatitis C virus replication in cell culture","volume":"281","author":"K Klumpp","year":"2006","journal-title":"J Biol Chem"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1365-2036.2010.04317.x","article-title":"Review article: specifically targeted anti-viral therapy for hepatitis C - a new era in therapy","volume":"32","author":"CM Lange","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1128\/AAC.49.5.2050-2058.2005","article-title":"Inhibitory effect of 2\u2032-substituted nucleosides on hepatitis C virus replication correlates with metabolic properties in replicon cells","volume":"49","author":"JE Tomassini","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1128\/AAC.01032-08","article-title":"Robust antiviral efficacy upon administration of a nucleoside analog to hepatitis C virus-infected chimpanzees","volume":"53","author":"SS Carroll","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1128\/AAC.00990-10","article-title":"Sustained viral response in a hepatitis C virus-infected chimpanzee via a combination of direct-acting antiviral agents","volume":"55","author":"DB Olsen","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"ref14","unstructured":"Pharmasset (Dec 16 2011) Pharmasset Announces Intent to Amend QUANTUM Trial. Press release."},{"key":"ref15","unstructured":"Bristol-Myers-Squibb (Aug 23 2012) Bristol-Myers Squibb Discontinues Development of BMS-986094, an Investigational NS5B Nucleotide for the Treatment of Hepatitis C. Press release."},{"key":"ref16","doi-asserted-by":"crossref","first-page":"4490","DOI":"10.1074\/jbc.M307938200","article-title":"Mitochondrial expression of the human equilibrative nucleoside transporter 1 (hENT1) results in enhanced mitochondrial toxicity of antiviral drugs","volume":"279","author":"Y Lai","year":"2004","journal-title":"J Biol Chem"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"14711","DOI":"10.1021\/bi035596s","article-title":"Toxicity of nucleoside analogues used to treat AIDS and the selectivity of the mitochondrial DNA polymerase","volume":"42","author":"H Lee","year":"2003","journal-title":"Biochemistry"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1136\/sti.77.3.158","article-title":"Mitochondrial toxicity and HIV therapy","volume":"77","author":"AJ White","year":"2001","journal-title":"Sex Transm Infect"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJM199510263331702","article-title":"Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B","volume":"333","author":"R McKenzie","year":"1995","journal-title":"N Engl J Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.1074\/jbc.274.8.4620","article-title":"Characterization of a dCTP transport activity reconstituted from human mitochondria","volume":"274","author":"EG Bridges","year":"1999","journal-title":"J Biol Chem"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ymeth.2010.05.001","article-title":"A transient kinetic approach to investigate nucleoside inhibitors of mitochondrial DNA polymerase gamma","volume":"51","author":"KS Anderson","year":"2010","journal-title":"Methods"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1212\/01.wnl.0000171861.30277.88","article-title":"Mitochondrial DNA copy number threshold in mtDNA depletion myopathy","volume":"65","author":"SE Durham","year":"2005","journal-title":"Neurology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/nrd1201","article-title":"Mitochondrial toxicity of NRTI antiviral drugs: an integrated cellular perspective","volume":"2","author":"W Lewis","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1146\/annurev.genet.39.110304.095751","article-title":"A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine","volume":"39","author":"DC Wallace","year":"2005","journal-title":"Annu Rev Genet"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0022-1759(93)90011-U","article-title":"The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity","volume":"160","author":"SP Crouch","year":"1993","journal-title":"J Immunol Methods"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1128\/AAC.00399-10","article-title":"PSI-7851, a pronucleotide of beta-D-2\u2032-deoxy-2\u2032-fluoro-2\u2032-C-methyluridine monophosphate, is a potent and pan-genotype inhibitor of hepatitis C virus replication","volume":"54","author":"AM Lam","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"3944","DOI":"10.1128\/AAC.48.10.3944-3953.2004","article-title":"A 7-deaza-adenosine analog is a potent and selective inhibitor of hepatitis C virus replication with excellent pharmacokinetic properties","volume":"48","author":"DB Olsen","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1586\/14737159.7.2.161","article-title":"Strategies to reduce late-stage drug attrition due to mitochondrial toxicity","volume":"7","author":"JA Dykens","year":"2007","journal-title":"Expert Rev Mol Diagn"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"16387","DOI":"10.1074\/jbc.M109.092676","article-title":"Identification of multiple rate-limiting steps during the human mitochondrial transcription cycle in vitro","volume":"285","author":"MF Lodeiro","year":"2010","journal-title":"J Biol Chem"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"5016","DOI":"10.1021\/bi200350d","article-title":"Human mitochondrial RNA polymerase: evaluation of the single-nucleotide-addition cycle on synthetic RNA\/DNA scaffolds","volume":"50","author":"ED Smidansky","year":"2011","journal-title":"Biochemistry"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"11979","DOI":"10.1074\/jbc.M210914200","article-title":"Inhibition of hepatitis C virus RNA replication by 2\u2032-modified nucleoside analogs","volume":"278","author":"SS Carroll","year":"2003","journal-title":"J Biol Chem"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1021\/jm030424e","article-title":"Structure-activity relationship of purine ribonucleosides for inhibition of hepatitis C virus RNA-dependent RNA polymerase","volume":"47","author":"AB Eldrup","year":"2004","journal-title":"J Med Chem"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.1021\/jm040068f","article-title":"Structure-activity relationship of heterobase-modified 2\u2032-C-methyl ribonucleosides as inhibitors of hepatitis C virus RNA replication","volume":"47","author":"AB Eldrup","year":"2004","journal-title":"J Med Chem"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"7202","DOI":"10.1021\/jm100863x","article-title":"Discovery of a beta-d-2\u2032-deoxy-2\u2032-alpha-fluoro-2\u2032-beta-C-methyluridine nucleotide prodrug (PSI-7977) for the treatment of hepatitis C virus","volume":"53","author":"MJ Sofia","year":"2010","journal-title":"J Med Chem"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1128\/AAC.48.2.651-654.2004","article-title":"Inhibition of the subgenomic hepatitis C virus replicon in huh-7 cells by 2\u2032-deoxy-2\u2032-fluorocytidine","volume":"48","author":"LJ Stuyver","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1146\/annurev.biochem.76.060305.152028","article-title":"DNA replication and transcription in mammalian mitochondria","volume":"76","author":"M Falkenberg","year":"2007","journal-title":"Annu Rev Biochem"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ymeth.2009.04.008","article-title":"Millisecond phase kinetic analysis of elongation catalyzed by human, yeast, and Escherichia coli RNA polymerase","volume":"48","author":"M Kireeva","year":"2009","journal-title":"Methods"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"30898","DOI":"10.1074\/jbc.M111.260844","article-title":"Interaction of RNA polymerase II fork loop 2 with downstream non-template DNA regulates transcription elongation","volume":"286","author":"ML Kireeva","year":"2011","journal-title":"J Biol Chem"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/toxsci\/kfm052","article-title":"Circumventing the Crabtree effect: replacing media glucose with galactose increases susceptibility of HepG2 cells to mitochondrial toxicants","volume":"97","author":"LD Marroquin","year":"2007","journal-title":"Toxicol Sci"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nature10435","article-title":"Structure of human mitochondrial RNA polymerase","volume":"478","author":"R Ringel","year":"2011","journal-title":"Nature"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"11256","DOI":"10.1128\/JVI.01028-07","article-title":"Lethal mutagenesis of poliovirus mediated by a mutagenic pyrimidine analogue","volume":"81","author":"JD Graci","year":"2007","journal-title":"J Virol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0167-4781(02)00459-1","article-title":"Promoting elongation with transcript cleavage stimulatory factors","volume":"1577","author":"RN Fish","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"16992","DOI":"10.1074\/jbc.M111.236968","article-title":"Nucleoside triphosphate pool asymmetry in mammalian mitochondria","volume":"286","author":"LJ Wheeler","year":"2011","journal-title":"J Biol Chem"},{"key":"ref44","first-page":"83","article-title":"Chloramphenicol toxicity","volume":"12","author":"D Holt","year":"1993","journal-title":"Adverse Drug React Toxicol Rev"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"29812","DOI":"10.1074\/jbc.M705274200","article-title":"Characterization of the metabolic activation of hepatitis C virus nucleoside inhibitor beta-D-2\u2032-Deoxy-2\u2032-fluoro-2\u2032-C-methylcytidine (PSI-6130) and identification of a novel active 5\u2032-triphosphate species","volume":"282","author":"H Ma","year":"2007","journal-title":"J Biol Chem"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/nar\/19.5.1073","article-title":"Cloning, expression and characterization of the human transcription elongation factor, TFIIS","volume":"19","author":"OJ Yoo","year":"1991","journal-title":"Nucleic Acids Res"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"14747","DOI":"10.1074\/jbc.272.23.14747","article-title":"Transcription elongation through DNA arrest sites. A multistep process involving both RNA polymerase II subunit RPB9 and TFIIS","volume":"272","author":"DE Awrey","year":"1997","journal-title":"J Biol Chem"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.antiviral.2009.04.003","article-title":"Comparison of HCV NS3 protease and NS5B polymerase inhibitor activity in 1a, 1b and 2a replicons and 2a infectious virus","volume":"83","author":"MS Paulson","year":"2009","journal-title":"Antiviral Res"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1128\/AAC.48.4.1089-1095.2004","article-title":"Role of purine nucleoside phosphorylase in interactions between 2\u2032,3\u2032-dideoxyinosine and allopurinol, ganciclovir, or tenofovir","volume":"48","author":"AS Ray","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1021\/mp900036s","article-title":"Nucleotide analogue prodrug tenofovir disoproxil enhances lymphoid cell loading following oral administration in monkeys","volume":"6","author":"L Durand-Gasselin","year":"2009","journal-title":"Mol Pharm"},{"key":"ref51","first-page":"Unit17 17","article-title":"Screening of hepatitis C virus inhibitors using genotype 1a HCV replicon cell lines","volume":"17","author":"M Robinson","year":"2011","journal-title":"Curr Protoc Microbiol Chapter"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1128\/AAC.00289-10","article-title":"Novel hepatitis C virus reporter replicon cell lines enable efficient antiviral screening against genotype 1a","volume":"54","author":"M Robinson","year":"2010","journal-title":"Antimicrob Agents Chemother"}],"container-title":["PLoS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.ppat.1003030","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T22:46:46Z","timestamp":1588978006000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1003030"}},"subtitle":[],"editor":[{"given":"Andrea","family":"Gamarnik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,11,15]]},"references-count":52,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2012,11,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1003030","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,15]]}}}